Matches in Wikidata for { <http://www.wikidata.org/entity/Q85014798> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q85014798 description "article scientifique publié en 2012" @default.
- Q85014798 description "artículu científicu espublizáu en setiembre de 2012" @default.
- Q85014798 description "scientific article published on 18 September 2012" @default.
- Q85014798 description "wetenschappelijk artikel" @default.
- Q85014798 description "наукова стаття, опублікована у вересні 2012" @default.
- Q85014798 name "An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for human epidermal growth factor receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cance" @default.
- Q85014798 name "An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for human epidermal growth factor receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cance" @default.
- Q85014798 type Item @default.
- Q85014798 label "An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for human epidermal growth factor receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cance" @default.
- Q85014798 label "An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for human epidermal growth factor receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cance" @default.
- Q85014798 prefLabel "An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for human epidermal growth factor receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cance" @default.
- Q85014798 prefLabel "An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for human epidermal growth factor receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cance" @default.
- Q85014798 P1433 Q85014798-F6BD717E-7AAE-4579-B43D-0A88497132D8 @default.
- Q85014798 P1476 Q85014798-D449E618-F513-4261-AD29-585309EDB5A4 @default.
- Q85014798 P2093 Q85014798-37ABC2A2-D012-4BC0-B07B-46DA4EB3ABEF @default.
- Q85014798 P2093 Q85014798-442970CA-B367-4848-8B36-C4DD12D2A2C6 @default.
- Q85014798 P2093 Q85014798-880598ED-750E-4640-BAE7-661B481C57C7 @default.
- Q85014798 P2093 Q85014798-89737AD8-24CF-415C-8032-D97CC168C32B @default.
- Q85014798 P2093 Q85014798-AF754FA9-8B8F-4AB1-976C-6103085C610E @default.
- Q85014798 P2093 Q85014798-B7DEDD58-D648-4C34-A635-99984F6361E7 @default.
- Q85014798 P2093 Q85014798-B9FC785E-569D-4AF6-A427-A57A5863D90B @default.
- Q85014798 P2093 Q85014798-D4475757-5B79-44ED-AE64-9A0D3C2EDA22 @default.
- Q85014798 P2093 Q85014798-D877318C-557B-45A8-8CD4-CD37E478F725 @default.
- Q85014798 P2093 Q85014798-DC5E78FC-5720-4A1F-8550-052A1D239129 @default.
- Q85014798 P2093 Q85014798-E5180008-7288-4D2C-916E-0AD77B18F7B8 @default.
- Q85014798 P2093 Q85014798-F9D88E22-26D4-4C29-BE4D-5A8EAFDE52F5 @default.
- Q85014798 P2093 Q85014798-FD9A5C6E-D1EE-4796-AF0C-C470B20BAD7D @default.
- Q85014798 P304 Q85014798-FB3C93F5-2A87-4FEA-9FF5-4E448951D831 @default.
- Q85014798 P31 Q85014798-F496A9F8-AB5D-41CB-BD60-DCCB6D1B71A7 @default.
- Q85014798 P356 Q85014798-27DA61B4-BEEF-4CDC-9D2E-043B405FCE24 @default.
- Q85014798 P433 Q85014798-ECBC9978-3BEE-46B5-B56D-EA46C2B07491 @default.
- Q85014798 P478 Q85014798-C065BD7C-3E38-41B0-8DFB-1A7348A44262 @default.
- Q85014798 P577 Q85014798-97A1549B-D330-441F-9558-6B0CCA446181 @default.
- Q85014798 P698 Q85014798-DE8C3EB5-67E6-44D3-9EF0-E72813F9F5BC @default.
- Q85014798 P921 Q85014798-094AAD02-F8A2-457D-ABA0-D92744CA72A2 @default.
- Q85014798 P921 Q85014798-19D135C2-4792-4664-B78D-1D2D1D86221A @default.
- Q85014798 P356 J.EJCA.2012.08.006 @default.
- Q85014798 P698 22999386 @default.
- Q85014798 P1433 Q332260 @default.
- Q85014798 P1476 "An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for human epidermal growth factor receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer" @default.
- Q85014798 P2093 "A Zimmer" @default.
- Q85014798 P2093 "D Cameron" @default.
- Q85014798 P2093 "H Bonnefoi" @default.
- Q85014798 P2093 "J Bartlett" @default.
- Q85014798 P2093 "J Bogaerts" @default.
- Q85014798 P2093 "J-Y Pierga" @default.
- Q85014798 P2093 "K M Koch" @default.
- Q85014798 P2093 "K Zaman" @default.
- Q85014798 P2093 "M Debled" @default.
- Q85014798 P2093 "M Fiche" @default.
- Q85014798 P2093 "M Fournier" @default.
- Q85014798 P2093 "M Nobahar" @default.
- Q85014798 P2093 "S Marreaud" @default.
- Q85014798 P304 "281-289" @default.
- Q85014798 P31 Q13442814 @default.
- Q85014798 P356 "10.1016/J.EJCA.2012.08.006" @default.
- Q85014798 P433 "2" @default.
- Q85014798 P478 "49" @default.
- Q85014798 P577 "2012-09-18T00:00:00Z" @default.
- Q85014798 P698 "22999386" @default.
- Q85014798 P921 Q415271 @default.
- Q85014798 P921 Q420436 @default.